News

A recent review article published in the European Journal of Health Economics examines NICE’s appraisals of non-small cell lung cancer (NSCLC) models from 2012 to 2022. There is substantial unmet…

With an increasing demand for health economics and HTAs in Europe and for us to continue co-creating and delivering results together with our clients, we are extremely thrilled to announce…

In our previous post, we summarized the three key learnings from the first 1.5 year of the DHTC’s existence. https://nhta.com/danish-health-technology-council-dhtc-key-learnings-from-the-first-year/ Based on these conclusions we consider it appropriate to provide…

Health outcomes in cost-effectiveness analyses are usually measured in quality-adjusted life years (QALYs) as it enables comparisons among various conditions. QALYs are typically based on health state preferences from a…